Levetiracetam
Total Payments
$123,500
Transactions
2
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $66,500 | 1 | 0 |
| 2021 | $57,000 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $123,500 | 2 | 100.0% |
Top Doctors Receiving Payments for Levetiracetam
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $123,500 | 2 |
Ad
Manufacturing Companies
- Dr.Reddy's Laboratories,Inc. $123,500
Product Information
- Type Drug
- Total Payments $123,500
- Total Doctors 0
- Transactions 2
About Levetiracetam
Levetiracetam is a drug associated with $123,500 in payments to 0 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is Dr.Reddy's Laboratories,Inc..
Payment data is available from 2021 to 2022. In 2022, $66,500 was paid across 1 transactions to 0 doctors.
The most common payment nature for Levetiracetam is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($123,500, 100.0% of total).